EcoDrugPlus

Cathepsin K

Ensembl ID : ENSACLG00000004303
Gene Symbol: CTSK
1 Cross references
225 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSACLG00000004182
Gene Symbol: LOC113032203
3 Cross references
225 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSACLG00000004206
Gene Symbol: CTSS
2 Cross references
229 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSACLG00000004271
Gene Symbol: CTSS
2 Cross references
231 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSACLG00000008684
Gene Symbol: CDC7
3 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSACLG00000020646
Gene Symbol: CHEK1
1 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSACLG00000009227
Gene Symbol: CHEK2
3 Cross references
206 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSACLG00000008928
Gene Symbol: CCKAR
4 Cross references
201 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSACLG00000004156
Gene Symbol: CCKBR
3 Cross references
195 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSACLG00000027072
Gene Symbol: LOC113016497
3 Cross references
198 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSACLG00000024835
Gene Symbol: LOC113037514
3 Cross references
240 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSACLG00000024918
Gene Symbol: LOC113037511
3 Cross references
241 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).